trial · primary record
[18F]-PI2620
Alzheimer Disease
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2022-10-26 |
| Primary endpoint | Comparability of visual assessment of PI-2620 tau PET images obtained after injection of high specific activity and low specific activity in AD and PSP patients. |
| Registry ID | NCT04715750 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:34.909Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04715750
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.